Tag Archives: drugs

From The Archives: Deductibles And Out-Of-Pocket Costs

Welcome to “From the Archives,” a new Health Affairs Blog series, where we take a timely topic and delve into the literature and history, from a Health Affairs angle, of course. We recently published a Web First with results from a Kaiser Family Foundation (KFF) survey of employers, showing...

September 29, 2015

How State Right-To-Try Laws Create False Expectations

Although these laws have created an expectation that terminally ill patients will be able to quickly access potentially life-saving treatments by being exempted from the rules of the U.S. Food and Drug Administration (FDA), this expectation is, quite simply, false.

May 22, 2015

In ‘Ensuring Timely Approval Of Generic Drugs,’ Safety Must Come First

If there was ever a time for an informed discussion about the purpose and use of Risk Evaluation and Mitigation Strategies, it is now.

May 14, 2015

Allow Evidence, Not Politics, To Drive Prevention: Lessons From Indiana’s HIV Outbreak

Indiana has recently become a place where health and politics intersect with striking consequences: One of the largest outbreaks of HIV ever identified in the U.S. continues to unfold in the state.

May 11, 2015

To Spur Medical Innovation, Make Corporate Cheaters Pay

The past decade has seen a relatively constant rate of newly approved drugs every year. The number has even jumped in the past few years. Yet, despite such encouraging trends, we are actually facing a crisis in drug innovation today.

April 30, 2015

Reducing Inappropriate Psychotropic Prescribing For Children And Youth In Foster Care

There is currently a much-needed national spotlight on the high rates of psychotropic medication use among children and youth in foster care, most of whom receive health coverage through Medicaid.

April 17, 2015

New Cures Require New Pricing Policies

One critical incentive for ongoing drug discovery and development is the temporary monopoly pricing that manufacturers can command for novel drugs. Yet this incentive, embedded in current patent and regulatory policy, does not guarantee that manufacturers will deliver novel products with...

April 16, 2015